55 episodes

In the podcast and at our events, we share inspiring stories from investors, entrepreneurs, and experts in an easy-to-understand and inspiring way.The LSG2G Partners invite the listeners to learn with them from the best and brightest minds behind disruptive businesses, innovative investments, prolific social movements, and technologies powering game-changing innovation. In intimate conversations, the host deconstructs the stories and strategies that he believes will move markets, change systems, and shape our future.Join the LSG2G Community: https://lsg2g.substack.com/

Beginner's Mind Christian Soschner

    • Business

In the podcast and at our events, we share inspiring stories from investors, entrepreneurs, and experts in an easy-to-understand and inspiring way.The LSG2G Partners invite the listeners to learn with them from the best and brightest minds behind disruptive businesses, innovative investments, prolific social movements, and technologies powering game-changing innovation. In intimate conversations, the host deconstructs the stories and strategies that he believes will move markets, change systems, and shape our future.Join the LSG2G Community: https://lsg2g.substack.com/

    #55: Peter Llewellyn-Davies - The Future of Life Science Entrepreneurship and Investment in Europe

    #55: Peter Llewellyn-Davies - The Future of Life Science Entrepreneurship and Investment in Europe

    In this conversation, I will talk with Peter Llewellyn-Davies, CEO of Apeiron and President of Biotech Austria about the Future of Life Science Entrepreneurship and Investment in Europe.

    Topics we discuss in the show:


    The Development of the Life Science Eco-System in EuropeHow Family Offices Support Life Science Companies in EuropeHow to Translate Science into BusinessDoes Europe Have a Culture of Success?And much more...
    Who is the Expert in the show?


    Peter Llewellyn-Davies CEO of Apeiron Biologics President of Biotech Austria 
    Shownotes:

    Video to the Episode

    Timestamps:
    (00:00) Opening
    (01:25) How did the Life Science Ecosystem Evolve?
    (03:22) The Biontech Success Story
    (04:10) How Did The Private and Publice Sector Evolve in Europe Since 2006?
    (05:49) What is Biotech Austria’s Mission?
    (07:00) How Many Members Does Biotech Austria Have in 2021?
    (09:10) Biotech Success Stories From Austria
    (11:40) Vienna, Austria, Local Life-Science-Eco-Systems and Biontech’s Success
    (13:45) Why is it a Great Decision to Start a Life Science Company in Austria?
    (16:26) Where Do Scientists Get Follow On Funding From?
    (18:30) How Helpful is the New European Investment Regulation for Foreign Investors?
    (21:00) Fundraising Challenges for Life Science Companies
    (24:00) Why Life Science Investments Are Attractive
    (25:50) How to Get in Touch With Biotech Austria
    Support the show (https://lsg2g.substack.com/subscribe?)

    • 27 min
    #54: Oliver Mavher and Michael Deichsel - Crypto Trading and Taxes - The Past, The Present, and The Future

    #54: Oliver Mavher and Michael Deichsel - Crypto Trading and Taxes - The Past, The Present, and The Future

    In this conversation, I will talk with Oliver Mavher and Michael Deichsel about Crypto Trading and taxes.

    Topics we discuss in the show:

    The questions that I consider relevant for everybody owning digital assets:
    What if someone gets paid in Bitcoin or other Cryptocurrencies? Is that a taxable event?What if someone invests in those novel digital assets and they gain in value?Does the location of the wallet or crypto exchange make any difference for taxation? Which tax law is applicable?What about European ETFs and their offshore counterparts that replicate the price of digital assets?What about investments in companies that invest in digital assets?Are there differences between retail investors, investment funds, and other institutional investors?And many more questions similar to the above
    Who are the Tax Experts in this Episode?

    I am delighted to welcome
    Oliver Mavher, KPMG andMichael Deichsel, KPMGto find answers to a multiverse of questions around crypto investments and taxes.
    Shownotes:
    Link
    Video
    Link
    Timestamps:
    (00:00) Opening What are the Real Life Tax Consequences of Trading with Cryptocurrencies?
    (02:47) Opening Oliver Mavher – Support for Digital Companies in Tax Matters
    (08:45) What are Security Token Offerings?
    (11:00) Opening Michael Deichsel – Crypto and Taxes
    (16:10) What is the Tokenization of the Economy?
    (18:15) Smart Contracts
    (24:15) What are Digital Assets in Terms of Tax Laws?
    (27:00) Bitcoin as Legal Tender in El Salvador?
    (29:07) Banking the Unbanked.
    (30:55) Cryptocurrencies and the Environment
    (34:13) What are crypto assets?
    (37:00) What are NFTs?
    (39:00) NFT and Taxations in Austria
    (45:30) Changes in Tax Laws in Austria
    (49:05) Taxable Events when BTC is used for salaries
    (54:15) Using Cryptocurrencies for everyday purchases – what are the taxable events?
    (56:45) Taxable events when trading cryptocurrencies outside Austria – A case for double taxation treaties?
    (01:00:00) Different Cases for Taxation and their Consequences
    (01:03:00) Taxation for Companies when holding Digital Assets
    (01:07:00) Expected changes to the tax laws
    (01:09:00) The difference in Taxation between Crypto Currencies and Digital Assets
    (01:13:00) Where to get advice for Crypto Taxation?
    Support the show (https://lsg2g.substack.com/subscribe?)

    • 1 hr 16 min
    #53: Alexander Schwartz and Ingrid Kelly Spillman - The Future of Early-Stage Deep Tech Investments in Europe

    #53: Alexander Schwartz and Ingrid Kelly Spillman - The Future of Early-Stage Deep Tech Investments in Europe

    In this conversation, I will talk with Alexander Schwartz and Ingrid Kelly Spillmann about the future of the Early-Stage Ecosystem in Europe.
    Speaker in the Episode:
    Alexander Schwartz joined IST cube in 2018 as a Partner. He has more than 15 years of experience in management consulting, eight of which with McKinsey & Company in Vienna and Chicago. His focus has been on strategy, innovation, and M&A in chemicals, materials, agriculture, and life science-related industries.
    Ingrid Kelly Spillman joined the IST Tech Transfer team in October 2018 after spending several years at the University of Vienna. Ingrid worked as a patent attorney in and for the pharma industry for more than a decade in different countries before moving into technology transfer. At IST cube, she will primarily be involved with Biotech, pharma, and chemistry startups, emphasizing intellectual property and legal matters.
    IST cube focuses on startups with a strong background in science and technology, such as academic spin-offs or young deep tech companies. The fund leads investment rounds in pre-seed and seed stages and has the ability for follow-on investments in later rounds. 
    Topics we discuss in the show:
    In this conversation, we discuss the Future Of the European Eco-System and talk about topics like:
    EcosystemsEarly-Stage InvestmentsWhat Are the Cornerstones of VC Investment StoriesFrom Science to BusinessThe IST Ecosystemand much more…Check Out the Speaker’s Profiles:
    Alexander SchwartzIngrid Kelly SpillmannIST cubeShownotes:
    Link
    Video
    LinkTimestamps:
    (00:00) Introduction
    (02:50) Introduction Alexander Schwartz
    (04:12) Introduction Ingrid Kelly Spillmann
    (06:05) How are IST, Twist, and IST Cube linked?
    (09:21) The Success Story of IST – from Greenfield Operations to Top 3 in 15 years
    (13:20) IST Cube’s Role in the Early-Stage Investment Community
    (16:45) The People behind IST Cube
    (19:00) Investment Focus of IST Cube
    (21:50) What is the attractive opportunity in early-stage investments?
    (26:00) When is the right time to reach out to VCs?
    (29:30) How Academic and Business Mindset work Together in Early-Stage Development
    (34:45) The Attitude for Fundraising Companies
    (38:20) What is the right timing for creating a spin-out company?
    (43:14) What deal structures are possible for early-stage companies?
    (48:25) Entrepreneurial Expertise in the European Eco-System
    (58:50) Startup Business Models in the Early-Stage Investment Eco-System
    (01:03:00) How Investors and Start-Ups Work Together to bring positive change to the World
    (01:06:00) The IST Cube Eco-System in 2021 – Build Around Collaboration and Open Innovation
    (01:09:15) How The Innovation Eco-System in Austria Collaborates to Support Companies to go from Zero to One
    (01:12:00) How IST Cube Helps Scientists Making the Transition from Academia to Business
    (01:17:00)Ideas for the European Eco-System
    (01:20:10) Failure Culture in Europe
    (01:23:30) Exit Strategies for Founders and Investors
    (01:28:35) Four Attributes Startups Should Have to Fit into VC Models.
    (01:32:40) What is the essential first step in the creation of a new company?
    Support the show (https://lsg2g.substack.com/subscribe?)

    • 1 hr 34 min
    #52: Caroline Heil - Driving the Future of Meat

    #52: Caroline Heil - Driving the Future of Meat

    The industry gains complexity, and I am happy that a speaker from the LSG2G community has dedicated time to speak about the Future of the Food Industry.
    Speaker in the Episode: Dr. Caroline E. Heil
    Since Jul. 1, 2021, Caroline has been CEO of The New Meat Company AG, a young stock-listed, purpose-driven impact investment company in Berlin focusing on alternative proteins. 
    Caroline is intrigued by the idea of revolutionizing the food industry, especially everything animal production-related, in an environmentally friendly, healthy, and sustainable way that will allow us to feed +10 billion people in the future.
    Before joining TNMC, Caroline worked for EY as a lawyer and part of the global EY Agribusiness Team. At the global EY Agribusiness Team, she covered legal agri- and food business aspects and was involved in strategic and innovative agri- and food business projects. Caroline i.a. gained experience in advising national and international corporate clients, banks, and financial investors on corporate aspects of M&A transactions and VC investments, including the performance of legal due diligence. 
    Her track record covers global and regional food- and agribusinesses, focusing on digital transformation of the larger agribusiness value, the alternative protein and meat market, food security impact driven by agricultural policy setting, and all questions related to sustainability environmental impact.
    The New Meat Co.
    The firm invests in game-changing companies and founders that disrupt the status quo of the meat industry to create nutritious, tasty, and sustainable meat alternatives that are good for everyone – animals, humans, and our planet.
    Following a buy and build strategy, the organization consolidates companies specializing in alternative meat–established pioneers and emerging game-changers.
    It also partners with innovative and value-driven individuals who aim to reduce (alternative) meat’s ecological footprint, increase its nutritional profile to support healthy living, and encourage animal welfare.
    Topics we discuss in the show:
    In this conversation, we discuss the Future Of the Food Industry and talk about topics like: 
    Alternative proteinsNutraceuticalsFunctional foodReworking the supply chain3d printing of foodPersonalized nutritionAnd much more…Follow Caroline E. Heil and The New Meat Co.:
    Caroline Heil on LinkedinThe New Meat Co on LinkedinShownotes:
    Article on Substack

    Timestamps:
    00:00 Opening
    02:25 The New Meat Company – New Trends in the Food Industry
    05:06 The Environmental Footprint of the Foot Industry in 2021
    08:08 Sustainability of the Food Industry
    10:14 Introduction Caroline Heil
    14:36 Innovation in the Meat Industry
    19:10 Sustainability of Analog Meat
    22:00 The Health Impact of Nutrition
    28:35 Solving the Global Distribution of Food with Modern Technology?
    34:38 The Hellofresh Case – High-Quality Food at Low Prices
    39:57 Consumer Trends in the Food Industry
    42:23 Insects as Protein Source?
    46:20 Lab-Grown Meat
    57:45 How Industry and StartUps Can Evolve Together
    01:00:00 Mission Statement of The New Meat Company
    01:03:20 What Invention Will Have the Biggest Impact on The Food Industry in This Decade?
    01:06:50 3D Printing of Food
    01:11:20 Longevity and the Food Industry
    Support the show (https://lsg2g.substack.com/subscribe?)

    • 1 hr 13 min
    #51: Saara Inkinen - The Future of Tech Transfer in a Post-Pandemic World

    #51: Saara Inkinen - The Future of Tech Transfer in a Post-Pandemic World

    Tech Transfer describes the process to bring scientific inventions from the discovery stage into companies for translational and clinical R&D.
    To gain more insights into this area, I invited a tech transfer expert from the LSG2G Community to this conversation.
    Speaker in this Episode is Saara Inkinen, Nordic Catalyst.
    Dr. Inkinen is a technology transfer and innovation management specialist based in Vienna, Austria. She originally came from Finland and had her first position in the chemical industry already in 2000. Since 2005, she has worked with industry-focused R&D, technology transfer, innovation management, funding, and strategic initiatives in an international environment.
    Dr. Inkinen is passionate about accelerating the development and commercialization of scientific technologies, and it is her mission to facilitate the transfer of research to business. She is a strong networker and has, for example, founded the Finnovation Champions technology transfer network in Finland in 2012. What ultimately motivates her in technology transfer and innovation management is the positive environmental, social, and societal impact that new technologies can help us create.
    For more details on Dr. Inkinen’s education and professional experience, please have a look at her LinkedIn profile.
    The Company - Nordic Catalyst
    Nordic Catalyst is a technology transfer and innovation management company founded by Dr. Saara Inkinen in 2018. Nordic Catalyst is located in Austria, and it works with an international client base consisting of both research organizations and companies.
    Questions we discuss in the show:
    What is Tech Transfer?Why is it necessary to bring ideas from universities into startups and companies?Is tech transfer biotech and pharma different from other tech areas?What challenges solve tech transfer?How has the environment changed with the pandemic?And much more…Follow Saara Inkinen and Nordic Catalyst:
    Saara Inkinen on LinkedinNordic Catalyst on LinkedinShownotes:
    Link to Article in the Member & Partner CommunityTimestamps:
    00:00 Introduction
    01:45 What is Tech Transfer
    02:30 The Tech Transfer Process
    04:05 Tech Transfer – Licensing, IP Sale and Startups
    05:00 Tech Transfer with Industrial Partners
    07:40 Why is Tech Transfer Necessary?
    13:20 Which Challenges Does TTO Face in the Life Science Networked Economy?
    16:37 How do different Skillsets Interact in Early Stage Development?
    19:35 Advantages and Disadvantages of the Startup Ecosystem for Deep Tech Companies
    23:10 How did the Pandemic Change the Environment for Tech Transfer
    27:17 How long does it take to turn a scientific idea into a finished product?
    30:52 What Challenges Exist in the Early Stage Development Field?
    33:40 How Do Business and Science Play Together?
    35:00 New Trends in Tech Transfer
    37:00 How Connected is the European Early Stage Industry?
    38:00 What is the First Step Towards Putting a scientific idea into a product?
    Support the show (https://lsg2g.substack.com/subscribe?)

    • 39 min
    #50: Dimitrios Tzalis - Insights Into Building CROs in Asia and in Europe

    #50: Dimitrios Tzalis - Insights Into Building CROs in Asia and in Europe

    In this conversation, we discuss the development of the European Pharma Eco-System, different business models generally accepted in the industry, and what it takes to lead a company to success.
    Today’s speaker is Dimitrios Tzalis.
    In the 90s, he received a Ph.D. from the University of California, San Diego, a Master of Science in Chemistry from the University of Chicago, and a Master of Science in Biochemistry from Ball State University in Muncie, Indiana USA.
    1998 he returned to Germany to found Taros Chemicals GmbH & Co. KG, one of Europe’s leading chemical CRO companies for drug discovery chemistry and custom synthesis services.
    Questions we discuss in the show:
    When and why did Dimitrios decide to found a novel company?How did Dimitrios find the Right Business Model?How did the industry evolve in India and Germany over the last two decades?How do you see the future of the life science industry globally after the push that it got with Sars Cov 2?And much more…Timestamps:
    00:00 Introduction
    04:25 Introduction Dimitrios Tzalis
    05:45 How to Start a Life Science Company During the Dot.com Bubble Times
    08:15 The Decision to Start a Company Rather Than Applying for a Job
    10:15 How did the European Life Science Eco-System Look Like in the 1990s?
    12:54 Where to Get Inspiration for Writing the Content of a Business Plan?
    16:54 The Structure of the Pharmaceutical Industry in the 90s/early 2000s
    20:15 The Networked Life Science Economy – From the 90s to 2021
    22:55 The Different Mindsets Needed to Bring an Idea to Market
    31:05 How to Fund Early-Stage Development Companies
    36:30 From Founding a Company in Germany to Founding a Company in India
    41:10 How Technology Changed Collaboration in the Last Two Decades
    44:25 Development of Cultural Similarities and Differences Between India and Germany Since 2000
    47:00 Is there a Global Convergence of Business Culture?
    52:17 The Pharma Industry in India – 2000-2021
    55:20 The Future of the Pharmaceutical Industry in India
    57:40 How Are Problems Approached in India vs. Europe?
    01:01:20 How Entrepreneurs Approach Problems
    01:03:15 Entrepreneurship & Passion
    01:06:00 The Role of Passion in Entrepreneurship
    01:10:20 The Role of Leadership in Building a Team
    01:12:26 Teamplay in Companies
    01:14:54 Life Science Business Models
    01:20:10 The Private and The Public Life Science World
    01:25:00 The Future of the Life Science Industry in Europe
    01:42:50 The European Culture Around Entrepreneurship
    01:50:00 Short-Term Thinking and Long Term Planning
    01:54:30 What is the Most Important Advice to First Time Founders
    Follow Dimitrios Tzalis and Taros:
    Linkedin Dimitrios TzalisLinkedin TarosShownotes:
    Das Netzwerkunternehmen, Elgar FleischThe Infinite Game, Simon SinekEpisode on other podcast PlatformsVideo to the EpisodeSupport the show (https://lsg2g.substack.com/subscribe?)

    • 1 hr 56 min

Top Podcasts In Business